Who Owns Prothena Stock?
NASDAQ: PRTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 90.93%
- Institutions (% of float)
- 118.04%
- Held by insiders
- 22.97%
- Institutional holders
- 260
- Institutions 77.0%
- Insiders 23.0%
- Public and other 0.0%
Who owns Prothena stock?
Institutional investors own about 90.9% of Prothena's shares, spread across 260 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 22.97% of PRTA.
The largest institutional holders are FMR, LLC (13.66%), Blackrock Inc. (11.17%) and Rubric Capital Management LP (9.74%). Together, the top 10 institutions control 56.1% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their PRTA positions and 6 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PRTA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 7.01M | 13.66% | -2.6% |
| Blackrock Inc. | 5.74M | 11.17% | +17.8% |
| Rubric Capital Management LP | 5.00M | 9.74% | 0.0% |
| Acadian Asset Management. LLC | 2.07M | 4.03% | +2.9% |
| State Street Corporation | 1.84M | 3.59% | -23.1% |
| Shaw D.E. & Co., Inc. | 1.61M | 3.14% | -8.6% |
| Vanguard Portfolio Management LLC | 1.57M | 3.06% | -5.0% |
| Adar1 Capital Management, LLC | 1.55M | 3.03% | -1.7% |
| Two Sigma Investments, LP | 1.26M | 2.46% | +4.9% |
| Palo Alto Investors Lp | 1.14M | 2.23% | -5.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PRTA
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.19M | 4.26% |
| iShares Trust-iShares Russell 2000 ETF | 1.12M | 2.18% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 904.17K | 1.76% |
| Vanguard Explorer Fund | 757.20K | 1.47% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 723.71K | 1.41% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 485.99K | 0.95% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 480.19K | 0.94% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 472.62K | 0.92% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 406.94K | 0.79% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 394.35K | 0.77% |
Frequently asked questions
Who is the largest shareholder of Prothena?
FMR, LLC is the largest institutional shareholder of PRTA, owning 13.66% of shares outstanding (7.01M shares) as of its latest 13F filing.
What percentage of Prothena is owned by institutions?
Institutions own about 90.9% of PRTA shares and 118.0% of the public float.
How much of Prothena do insiders own?
Insiders, such as officers and directors, own about 22.97% of PRTA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.